RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Cost-effectiveness analysis of recombinant zoster vaccine for the prevention of herpes zoster in immunocompromised adults diagnosed with select cancers in the United States

Curran, D., Patterson, B., Carrico , J., Salem, A., La, E., Lorenc, S., Hicks, K., Poston, S., & Carpenter, C. (2021). Cost-effectiveness analysis of recombinant zoster vaccine for the prevention of herpes zoster in immunocompromised adults diagnosed with select cancers in the United States. American Journal of Hematology, 96(S1), Article S26. https://doi.org/10.1002/ajh.26351

10.1002/ajh.26351

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

Navigate to Barbara L. Kroner

Barbara L. Kroner

Navigate to Barri Burrus

Barri Burrus

Navigate to Cynthia Salmons

Cynthia Salmons

Navigate to Dan Pratt

Dan Pratt

Navigate to Donna Womack

Donna Womack

Navigate to Gary A. Zarkin

Gary A. Zarkin

Navigate to Gayle Bieler

Gayle Bieler

Navigate to J. Todd Ennis

J. Todd Ennis